Guéguinou, Maxime http://orcid.org/0000-0002-5793-2082
Ibrahim, Sajida
Bourgeais, Jérôme
Robert, Alison
Pathak, Trayambak
Zhang, Xuexin
Crottès, David
Dupuy, Jacques
Ternant, David
Monbet, Valérie
Guibon, Roseline
Flores-Romero, Hector
Lefèvre, Antoine
Lerondel, Stéphanie
Le Pape, Alain
Dumas, Jean-François
Frank, Philippe G.
Girault, Alban
Chautard, Romain
Guéraud, Françoise
García-Sáez, Ana J.
Ouaissi, Mehdi
Emond, Patrick
Sire, Olivier
Hérault, Olivier
Fromont-Hankard, Gaëlle
Vandier, Christophe
Tougeron, David
Trebak, Mohamed
Raoul, William
Lecomte, Thierry
Funding for this research was provided by:
Ligue Contre le Cancer
Conseil Régional du Centre-Val de Loire (Opticorégumine)
Inserm
ARFMAD
Université de Tours
Article History
Received: 31 January 2022
Revised: 5 April 2022
Accepted: 15 April 2022
First Online: 8 May 2022
Declarations
:
: No competing interests were disclosed by authors.
: COLOMIN study was designed in accordance with legal requirements and the Declaration of Helsinki, and was approved by the ethics committee of CHU Poitiers and CHRU Tours, France (Comité de protection des personnes Ouest III, no. DC-2008-565 and no. 2018-039).